Global Novel Oral AntiCoagulants (NOAC) Market Insights, Forecast to 2025

Publisher Name :
Date: 25-Feb-2019
No. of pages: 122
Inquire Before Buying

The global Novel Oral AntiCoagulants (NOAC) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Novel Oral AntiCoagulants (NOAC) market based on company, product type, end user and key regions.

This report studies the global market size of Novel Oral AntiCoagulants (NOAC) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Novel Oral AntiCoagulants (NOAC) in these regions.

This research report categorizes the global Novel Oral AntiCoagulants (NOAC) market by top players/brands, region, type and end user. This report also studies the global Novel Oral AntiCoagulants (NOAC) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Johnson & Johnson

- Bristol-Myers Squibb

- Boehringer Ingelheim

- Sanofi

- Daiichi Sankyo

- Armatheon

- Aspen

- AstraZeneca

- Bayer

- Cellceutix

- Cosmo Pharmaceuticals

- CSL Behring

- Eisai

- GSK

- Marathon Pharmaceuticals

- Ockham Biotech

- Perosphere

Market size by Product

- Direct Thrombin Inhibitors

- Direct Factor Xa Inhibitors

Market size by End User

- Deep Vein Thrombosis (DVT)

- Pulmonary Embolism

- Acute Coronary Syndrome

- Hemodialysis

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Novel Oral AntiCoagulants (NOAC) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Novel Oral AntiCoagulants (NOAC) market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Novel Oral AntiCoagulants (NOAC) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Novel Oral AntiCoagulants (NOAC) submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Novel Oral AntiCoagulants (NOAC) are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Novel Oral AntiCoagulants (NOAC) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Novel Oral AntiCoagulants (NOAC) Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Novel Oral AntiCoagulants (NOAC) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Novel Oral AntiCoagulants (NOAC) Market Size Growth Rate by Product
1.4.2 Direct Thrombin Inhibitors
1.4.3 Direct Factor Xa Inhibitors
1.5 Market by End User
1.5.1 Global Novel Oral AntiCoagulants (NOAC) Market Size Growth Rate by End User
1.5.2 Deep Vein Thrombosis (DVT)
1.5.3 Pulmonary Embolism
1.5.4 Acute Coronary Syndrome
1.5.5 Hemodialysis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Novel Oral AntiCoagulants (NOAC) Market Size
2.1.1 Global Novel Oral AntiCoagulants (NOAC) Revenue 2014-2025
2.1.2 Global Novel Oral AntiCoagulants (NOAC) Sales 2014-2025
2.2 Novel Oral AntiCoagulants (NOAC) Growth Rate by Regions
2.2.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Regions
2.2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Novel Oral AntiCoagulants (NOAC) Sales by Manufacturers
3.1.1 Novel Oral AntiCoagulants (NOAC) Sales by Manufacturers
3.1.2 Novel Oral AntiCoagulants (NOAC) Sales Market Share by Manufacturers
3.1.3 Global Novel Oral AntiCoagulants (NOAC) Market Concentration Ratio (CR5 and HHI)
3.2 Novel Oral AntiCoagulants (NOAC) Revenue by Manufacturers
3.2.1 Novel Oral AntiCoagulants (NOAC) Revenue by Manufacturers (2014-2019)
3.2.2 Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers (2014-2019)
3.3 Novel Oral AntiCoagulants (NOAC) Price by Manufacturers
3.4 Novel Oral AntiCoagulants (NOAC) Manufacturing Base Distribution, Product Types
3.4.1 Novel Oral AntiCoagulants (NOAC) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Novel Oral AntiCoagulants (NOAC) Product Type
3.4.3 Date of International Manufacturers Enter into Novel Oral AntiCoagulants (NOAC) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Product
4.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Product
4.3 Novel Oral AntiCoagulants (NOAC) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Novel Oral AntiCoagulants (NOAC) Breakdown Data by End User
6 North America
6.1 North America Novel Oral AntiCoagulants (NOAC) by Countries
6.1.1 North America Novel Oral AntiCoagulants (NOAC) Sales by Countries
6.1.2 North America Novel Oral AntiCoagulants (NOAC) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Novel Oral AntiCoagulants (NOAC) by Product
6.3 North America Novel Oral AntiCoagulants (NOAC) by End User
7 Europe
7.1 Europe Novel Oral AntiCoagulants (NOAC) by Countries
7.1.1 Europe Novel Oral AntiCoagulants (NOAC) Sales by Countries
7.1.2 Europe Novel Oral AntiCoagulants (NOAC) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Novel Oral AntiCoagulants (NOAC) by Product
7.3 Europe Novel Oral AntiCoagulants (NOAC) by End User
8 Asia Pacific
8.1 Asia Pacific Novel Oral AntiCoagulants (NOAC) by Countries
8.1.1 Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales by Countries
8.1.2 Asia Pacific Novel Oral AntiCoagulants (NOAC) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Novel Oral AntiCoagulants (NOAC) by Product
8.3 Asia Pacific Novel Oral AntiCoagulants (NOAC) by End User
9 Central & South America
9.1 Central & South America Novel Oral AntiCoagulants (NOAC) by Countries
9.1.1 Central & South America Novel Oral AntiCoagulants (NOAC) Sales by Countries
9.1.2 Central & South America Novel Oral AntiCoagulants (NOAC) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Novel Oral AntiCoagulants (NOAC) by Product
9.3 Central & South America Novel Oral AntiCoagulants (NOAC) by End User
10 Middle East and Africa
10.1 Middle East and Africa Novel Oral AntiCoagulants (NOAC) by Countries
10.1.1 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales by Countries
10.1.2 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Novel Oral AntiCoagulants (NOAC) by Product
10.3 Middle East and Africa Novel Oral AntiCoagulants (NOAC) by End User
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Company Business Overview
11.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Products Offered
11.1.5 Johnson & Johnson Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Company Business Overview
11.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Products Offered
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Company Business Overview
11.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Products Offered
11.3.5 Boehringer Ingelheim Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Novel Oral AntiCoagulants (NOAC) Products Offered
11.4.5 Sanofi Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Company Business Overview
11.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Products Offered
11.5.5 Daiichi Sankyo Recent Development
11.6 Armatheon
11.6.1 Armatheon Company Details
11.6.2 Company Business Overview
11.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Armatheon Novel Oral AntiCoagulants (NOAC) Products Offered
11.6.5 Armatheon Recent Development
11.7 Aspen
11.7.1 Aspen Company Details
11.7.2 Company Business Overview
11.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Aspen Novel Oral AntiCoagulants (NOAC) Products Offered
11.7.5 Aspen Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 Company Business Overview
11.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 AstraZeneca Novel Oral AntiCoagulants (NOAC) Products Offered
11.8.5 AstraZeneca Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Business Overview
11.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bayer Novel Oral AntiCoagulants (NOAC) Products Offered
11.9.5 Bayer Recent Development
11.10 Cellceutix
11.10.1 Cellceutix Company Details
11.10.2 Company Business Overview
11.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Cellceutix Novel Oral AntiCoagulants (NOAC) Products Offered
11.10.5 Cellceutix Recent Development
11.11 Cosmo Pharmaceuticals
11.12 CSL Behring
11.13 Eisai
11.14 GSK
11.15 Marathon Pharmaceuticals
11.16 Ockham Biotech
11.17 Perosphere
12 Future Forecast
12.1 Novel Oral AntiCoagulants (NOAC) Market Forecast by Regions
12.1.1 Global Novel Oral AntiCoagulants (NOAC) Sales Forecast by Regions 2019-2025
12.1.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Forecast by Regions 2019-2025
12.2 Novel Oral AntiCoagulants (NOAC) Market Forecast by Product
12.2.1 Global Novel Oral AntiCoagulants (NOAC) Sales Forecast by Product 2019-2025
12.2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Forecast by Product 2019-2025
12.3 Novel Oral AntiCoagulants (NOAC) Market Forecast by End User
12.4 North America Novel Oral AntiCoagulants (NOAC) Forecast
12.5 Europe Novel Oral AntiCoagulants (NOAC) Forecast
12.6 Asia Pacific Novel Oral AntiCoagulants (NOAC) Forecast
12.7 Central & South America Novel Oral AntiCoagulants (NOAC) Forecast
12.8 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Novel Oral AntiCoagulants (NOAC) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Novel Oral AntiCoagulants (NOAC) Product Picture
Table Novel Oral AntiCoagulants (NOAC) Market Segments
Table Key Manufacturers Novel Oral AntiCoagulants (NOAC) Covered
Table Global Novel Oral AntiCoagulants (NOAC) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Product 2014-2025
Figure Direct Thrombin Inhibitors Product Picture
Table Major Manufacturers of Direct Thrombin Inhibitors
Figure Direct Factor Xa Inhibitors Product Picture
Table Major Manufacturers of Direct Factor Xa Inhibitors
Table Global Novel Oral AntiCoagulants (NOAC) Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Deep Vein Thrombosis (DVT)
Figure Pulmonary Embolism
Figure Acute Coronary Syndrome
Figure Hemodialysis
Figure Others
Figure Novel Oral AntiCoagulants (NOAC) Report Years Considered
Figure Global Novel Oral AntiCoagulants (NOAC) Market Size 2014-2025 (Million US$)
Figure Global Novel Oral AntiCoagulants (NOAC) Sales 2014-2025 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Novel Oral AntiCoagulants (NOAC) Sales by Regions 2014-2019 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Regions 2014-2019
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Regions 2014-2019
Figure 2018 Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Regions
Table Global Novel Oral AntiCoagulants (NOAC) Revenue by Regions 2014-2019 (Million US$)
Table Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions 2014-2019
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions
Table Global Novel Oral AntiCoagulants (NOAC) Sales by Manufacturers (2014-2019) (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Share by Manufacturers (2014-2019)
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Novel Oral AntiCoagulants (NOAC) Revenue by Manufacturers (2014-2019) (Million USD)
Table Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers (2014-2019)
Figure Novel Oral AntiCoagulants (NOAC) Value Share by Manufacturers in 2018
Table Key Manufacturers Novel Oral AntiCoagulants (NOAC) Price (2014-2019) (USD/Unit)
Table Novel Oral AntiCoagulants (NOAC) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Novel Oral AntiCoagulants (NOAC) Product Type
Table Date of International Manufacturers Enter into Novel Oral AntiCoagulants (NOAC) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Novel Oral AntiCoagulants (NOAC) Sales by Product (2014-2019) (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Share by Product (2014-2019)
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Product (2014-2019)
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Product in 2018
Table Global Novel Oral AntiCoagulants (NOAC) Revenue by Product (2014-2019) (Million US$)
Table Global Novel Oral AntiCoagulants (NOAC) Revenue Share by Product (2014-2019)
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Product (2014-2019)
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Product in 2018
Table Novel Oral AntiCoagulants (NOAC) Price by Product 2014-2019 (USD/Unit)
Table Global Novel Oral AntiCoagulants (NOAC) Sales by End User (2014-2019) (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Share by End User (2014-2019)
Figure Global Sales Novel Oral AntiCoagulants (NOAC) Market Share by End User (2014-2019)
Figure Global Sales Novel Oral AntiCoagulants (NOAC) Market Share by End User in 2018
Figure North America Novel Oral AntiCoagulants (NOAC) Sales Growth Rate 2014-2019 (K Units)
Figure North America Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Novel Oral AntiCoagulants (NOAC) Sales by Countries (2014-2019) (K Units)
Table North America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries
Table North America Novel Oral AntiCoagulants (NOAC) Revenue by Countries (2014-2019) (Million US$)
Table North America Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries
Figure United States Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure United States Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Canada Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Novel Oral AntiCoagulants (NOAC) Sales by Product (2014-2019) (K Units)
Table North America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Product (2014-2019)
Figure 2018 North America Novel Oral AntiCoagulants (NOAC) Market Share by Product
Table North America Novel Oral AntiCoagulants (NOAC) Sales by End User (2014-2019) (K Units)
Table North America Novel Oral AntiCoagulants (NOAC) Sales Market Share by End User (2014-2019)
Figure 2018 North America Novel Oral AntiCoagulants (NOAC) Market Share by End User
Figure Europe Novel Oral AntiCoagulants (NOAC) Sales Growth Rate 2014-2019 (K Units)
Figure Europe Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Novel Oral AntiCoagulants (NOAC) Sales by Countries (2014-2019) (K Units)
Table Europe Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries
Table Europe Novel Oral AntiCoagulants (NOAC) Revenue by Countries (2014-2019) (Million US$)
Table Europe Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries
Figure Germany Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Germany Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure France Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure UK Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Italy Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Russia Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Novel Oral AntiCoagulants (NOAC) Sales by Product (2014-2019) (K Units)
Table Europe Novel Oral AntiCoagulants (NOAC) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Novel Oral AntiCoagulants (NOAC) Market Share by Product
Table Europe Novel Oral AntiCoagulants (NOAC) Sales by End User (2014-2019) (K Units)
Table Europe Novel Oral AntiCoagulants (NOAC) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Novel Oral AntiCoagulants (NOAC) Market Share by End User
Figure Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries
Table Asia Pacific Novel Oral AntiCoagulants (NOAC) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries
Figure China Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure China Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure India Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Australia Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales by Product (2014-2019) (K Units)
Table Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Novel Oral AntiCoagulants (NOAC) Market Share by Product
Table Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales by End User (2014-2019) (K Units)
Table Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Novel Oral AntiCoagulants (NOAC) Market Share by End User
Figure Central & South America Novel Oral AntiCoagulants (NOAC) Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Novel Oral AntiCoagulants (NOAC) Sales by Countries (2014-2019) (K Units)
Table Central & South America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries
Table Central & South America Novel Oral AntiCoagulants (NOAC) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries
Figure Brazil Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Novel Oral AntiCoagulants (NOAC) Sales by Product (2014-2019) (K Units)
Table Central & South America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Novel Oral AntiCoagulants (NOAC) Market Share by Product
Table Central & South America Novel Oral AntiCoagulants (NOAC) Sales by End User (2014-2019) (K Units)
Table Central & South America Novel Oral AntiCoagulants (NOAC) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Novel Oral AntiCoagulants (NOAC) Market Share by End User
Figure Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales Market Share by Countries
Table Middle East and Africa Novel Oral AntiCoagulants (NOAC) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Countries
Figure GCC Countries Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Novel Oral AntiCoagulants (NOAC) Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Market Share by Product
Table Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Market Share by End User
Table Johnson & Johnson Company Details
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Sanofi Company Details
Table Sanofi Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Recent Development
Table Armatheon Company Details
Table Armatheon Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Armatheon Recent Development
Table Aspen Company Details
Table Aspen Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Aspen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Bayer Company Details
Table Bayer Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Cellceutix Company Details
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cellceutix Recent Development
Table Cosmo Pharmaceuticals Company Details
Table CSL Behring Company Details
Table Eisai Company Details
Table GSK Company Details
Table Marathon Pharmaceuticals Company Details
Table Ockham Biotech Company Details
Table Perosphere Company Details
Table Global Novel Oral AntiCoagulants (NOAC) Sales Forecast by Regions 2019-2025 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Market Share Forecast by Regions 2019-2025
Table Global Novel Oral AntiCoagulants (NOAC) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share Forecast by Regions 2019-2025
Table Global Novel Oral AntiCoagulants (NOAC) Sales Forecast by Product 2019-2025 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Market Share Forecast by Product 2019-2025
Table Global Novel Oral AntiCoagulants (NOAC) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share Forecast by Product 2019-2025
Table Global Novel Oral AntiCoagulants (NOAC) Sales Forecast by End User 2019-2025 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Market Share Forecast by End User 2019-2025
Figure North America Novel Oral AntiCoagulants (NOAC) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Novel Oral AntiCoagulants (NOAC) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Novel Oral AntiCoagulants (NOAC) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Novel Oral AntiCoagulants (NOAC) Value Chain
Table Novel Oral AntiCoagulants (NOAC) Customers List
Table Novel Oral AntiCoagulants (NOAC) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Cleanroom Technology Market Forecast 2019-2027
    Published: 26-Jun-2019        Price: US 2500 Onwards        Pages: 158
    KEY FINDINGS The quality certifications (ISO checks, NSQHS, etc.) for certain products require them to be handled in a cleanroom environment, for minimized levels of possible contamination. So, the dependency on cleanroom technology has witnessed significant popularity to meet the respective contamination check requirements. The global cleanroom technology market is anticipated to grow at a CAGR of 5.53% from 2019 to 2027 and to generate revenue of $XX by 2027. The forecast period ......
  • Global Olaparib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 26-Jun-2019        Price: US 3480 Onwards        Pages: 108
    Scope of the Report: The worldwide market for Olaparib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Olaparib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. ......
  • Global Tenofovir/Alafenamide Compound Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 26-Jun-2019        Price: US 3480 Onwards        Pages: 116
    Scope of the Report: The worldwide market for Tenofovir/Alafenamide Compound Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Tenofovir/Alafenamide Compound Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based......
  • Global Daclatasvir Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 26-Jun-2019        Price: US 3480 Onwards        Pages: 120
    Scope of the Report: The worldwide market for Daclatasvir is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Daclatasvir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Regorafenib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 26-Jun-2019        Price: US 3480 Onwards        Pages: 105
    Scope of the Report: The worldwide market for Regorafenib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Regorafenib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Obeticholic Acid Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 26-Jun-2019        Price: US 3480 Onwards        Pages: 106
    Scope of the Report: The worldwide market for Obeticholic Acid is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Obeticholic Acid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and app......
  • Global Corevedilol Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 26-Jun-2019        Price: US 3480 Onwards        Pages: 139
    Scope of the Report: The worldwide market for Corevedilol is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Corevedilol in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Ibrutinib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 26-Jun-2019        Price: US 3480 Onwards        Pages: 117
    Scope of the Report: The worldwide market for Ibrutinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Ibrutinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Ruxolitinib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 26-Jun-2019        Price: US 3480 Onwards        Pages: 103
    Scope of the Report: The worldwide market for Ruxolitinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Ruxolitinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs